Influenza Vaccine Market Set For Stupendous Growth By 2012
Extensive research and profound analysis performed for the market together exhibited a high growth potential market with promising future growth prospects. With increasing researches to develop new alternative technologies for manufacturing pandemic flu vaccines as well as with the support of governments across the globe, the market is projected to grow at a CAGR of around 6 percent during 2009-2012.
The research firm has done thorough research and prudent analysis of global vaccine market and have identified some critical factors acting as a catalyst for the industry's current and future growth. The report reveals that new vaccination coverage targets set by international health authorities are driving renewed investments in the influenza market.
Moreover, the key benefits of influenza vaccines such as having a higher probability of R&D success and long product lifecycles with a negligible threat of generic substitution will pave the way for the growth of the market in coming years by drawing more investments.
Based on some concrete market fundamentals, the research firm has anticipated that the influenza vaccine market will register one of the most impressive growth rates in the overall vaccine market globally during our forecast period and will become one of the most dominating market segments in the vaccine industry.
What is your opinion of this subject?
Have your say and discuss with your peers on the InfoGrok community.
Participate by posting your comments now.